samedan logo

 
 
spacer
home > login
LOGIN
Please use the form below to log in. "Remeber me" function uses Cookies, please make sure this feature is not disabled in your browser settings.

Member login

E-mail address:

Password:
Remember me

 

If you lost your password please use the form provided below to get a new one.

Get new password

E-mail address:

 

 

spacer

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>


News and Press Releases

UK Medicines and Healthcare Products Regulatory Agency (MHRA) Issues an Early Access to Medicines Scheme (EAMS) Positive Scientific Opinion for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Feltham (Merck) Merck announced today that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued an Early Access to Medicines Scheme (EAMS) positive scientific opinion for tepotinib for the treatment of adult patients with advanced Non-Small Cell Lung Cancer (NSCLC) harbouring mesenchymal-epithelial transition factor gene (MET) exon 14 (METex14) skipping alterations.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement